The Chinese vaccine against Covid by Sinovac “is a further possibility” in the fight against the virus “but the efficacy data does not seem extraordinary to me. We will see what the EMA will decide. At the moment I am more interested in Curevac and the other Western vaccines”. This Chinese vaccine has been used a lot in the Emirates and Middle Eastern countries, it is one more weapon. Let’s see if Ema will give the go ahead and make it available in Europe. “So to Adnkronos Salute Matteo Bassetti, director of the Infectious Diseases Clinic of the San Martino hospital in Genoa and member of the Covid-19 crisis unit of Liguria, comments on the start of the evaluation process by Ema of the vaccine developed by Sinovac Life Sciences Co. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has started the rolling review process ) for the inactivated vaccine, which contains the coronavirus that is not capable of causing disease. The EMA has made it known that “it will evaluate the data as soon as they become available to decide if the benefits outweigh the risks”.